Drug
Pegunigalsidase Alfa
Pegunigalsidase Alfa: highest development phase Phase 3, developed by Chiesi Farmaceutici. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Chiesi Farmaceutici
Trials
| Drug | Phase | Indication |
|---|---|---|
| Pegunigalsidase alfa NCT03180840 | Phase 3 | Fabry Disease |
Latest
No recent events.
Follow Pegunigalsidase Alfa on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.